Search research articles
Contact Us
Filters
Showing results (151-160 of 223) with videos related to
Page
of 23
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
August 7, 2024
Heterogeneity in advanced pulmonary sarcomatoid carcinoma and its efficacy to immune checkpoint inhibitors
Mengqing Xie, Tianqing Chu, Xiaorong Dong, et al.
Translational Lung Cancer Research
|
November 4, 2021
Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy
Xin Yu, Jiaqi Li, Lingyun Ye, et al.
Oncotarget
|
November 29, 2017
The role of endobronchial ultrasound elastography in the diagnosis of mediastinal and hilar lymph nodes
Ye Gu, Hong Shi, Chunxia Su, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 20, 2019
Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer
Sha Zhao, Guanghui Gao, Wei Li, et al.
Translational Oncology
|
September 3, 2014
Peripheral blood for epidermal growth factor receptor mutation detection in non-small cell lung cancer patients
Xuefei Li, Ruixin Ren, Shengxiang Ren, et al.
BMC Cancer
|
March 9, 2018
Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers
Tao Jiang, Xiaofeng Xu, Meng Qiao, et al.
ACS Applied Materials & Interfaces
|
August 8, 2022
Oncolytic Impediment/Promotion Balance Disruption by Sonosensitizer-Free Nanoplatforms Unfreezes Autophagy-Induced Resistance to Sonocatalytic Therapy
Lu Lu, Taixia Wang, Chao Fang, et al.
NPJ Precision Oncology
|
February 13, 2021
Characterization of evolution trajectory and immune profiling of brain metastasis in lung adenocarcinoma
Tao Jiang, Yan Yan, Kun Zhou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 19, 2017
Comprehensive Analysis of EGFR-Mutant Abundance and Its Effect on Efficacy of EGFR TKIs in Advanced NSCLC with EGFR Mutations
Xuefei Li, Weijing Cai, Guohua Yang, et al.
Cancer
|
December 15, 2018
Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer
Terry L Ng, Yiwei Liu, Anastasios Dimou, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 223) with videos related to
Sort By:
Page
of 23
European Journal of Cancer (Oxford, England : 1990)
|
August 7, 2024
Heterogeneity in advanced pulmonary sarcomatoid carcinoma and its efficacy to immune checkpoint inhibitors
Mengqing Xie, Tianqing Chu, Xiaorong Dong, et al.
Translational Lung Cancer Research
|
November 4, 2021
Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy
Xin Yu, Jiaqi Li, Lingyun Ye, et al.
Oncotarget
|
November 29, 2017
The role of endobronchial ultrasound elastography in the diagnosis of mediastinal and hilar lymph nodes
Ye Gu, Hong Shi, Chunxia Su, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 20, 2019
Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer
Sha Zhao, Guanghui Gao, Wei Li, et al.
Translational Oncology
|
September 3, 2014
Peripheral blood for epidermal growth factor receptor mutation detection in non-small cell lung cancer patients
Xuefei Li, Ruixin Ren, Shengxiang Ren, et al.
BMC Cancer
|
March 9, 2018
Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers
Tao Jiang, Xiaofeng Xu, Meng Qiao, et al.
ACS Applied Materials & Interfaces
|
August 8, 2022
Oncolytic Impediment/Promotion Balance Disruption by Sonosensitizer-Free Nanoplatforms Unfreezes Autophagy-Induced Resistance to Sonocatalytic Therapy
Lu Lu, Taixia Wang, Chao Fang, et al.
NPJ Precision Oncology
|
February 13, 2021
Characterization of evolution trajectory and immune profiling of brain metastasis in lung adenocarcinoma
Tao Jiang, Yan Yan, Kun Zhou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 19, 2017
Comprehensive Analysis of EGFR-Mutant Abundance and Its Effect on Efficacy of EGFR TKIs in Advanced NSCLC with EGFR Mutations
Xuefei Li, Weijing Cai, Guohua Yang, et al.
Cancer
|
December 15, 2018
Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer
Terry L Ng, Yiwei Liu, Anastasios Dimou, et al.
Page
of 23